Work

Abstract PS4-04-26: Anti-tumor activity of ATNM-400, a first-in-class Actinium-225 antibody radioconjugate, in tamoxifen and trastuzumab resistant breast cancer models

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-04-26

Authors: A. Kamal, A. S. Chin, S. Mukherjee, J. Li, K. Peregrina, D. Lewis, H. Sethi, L. Xu, D. Patel, M. Roy, A. Bardia

Institutions: Actinium Pharmaceuticals (United States), University of California, Los Angeles

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129657142

Cites:

Cited by:

Related to: